Atrial natriureticpeptide-28 (human) (9CI) cas no:89213-87-6
Synonyms: Atriopeptin-33(rat), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-;1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane,cyclic peptide deriv.;(1-28)-Human atrial natriuretic peptide;13: PN:US20060171920 SEQID: 13 claimed protein;2: PN: US6028055 SEQID: 51 claimedprotein;4: PN: US20090011997 SEQID: 2 claimed protein;56: PN: US20090011997SEQID: 59 claimed protein;82: PN: US20080153747 SEQID: 82 claimed protein;Atriopeptin (human a-component);Carperitide;Horse atrial natriuretic peptide-28;Humanatrial natriuretic factor (99-126);Human atrial natriuretic peptide (1-28);Human atrial natriuretic peptide (99-126);Human atriopeptin(1-28);Humanatriopeptin(99-126);Human atriopeptin-28;Human a-atrial natriuretic factor;Human a-atrial natriuretic factor(1-28);Human a-atrial natriuretic peptide;Human a-atriopeptin;L-Tyrosine,L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-,cyclic (7?;SUN 4936;[99-126]-Human proatriopeptin;a-Atriopeptin (human);a-Human atrial natriuretic hormone;a-Human atrial natriuretic peptide (1-28);a-Human atrial natriureticpolypeptide;a-Humanatriopeptin(1-28);
NameAtrial natriureticpeptide-28 (human) (9CI)
CAS89213-87-6
SynonymsAtriopeptin-33(rat), 1-de-L-leucine-2-de-L-alanine-3-deglycine-4-de-L-proline-5-de-L-arginine-17-L-methionine-;1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane,cyclic peptide deriv.;(1-28)-Human atrial natriuretic peptide;13: PN:US20060171920 SEQID: 13 claimed protein;2: PN: US6028055 SEQID: 51 claimedprotein;4: PN: US20090011997 SEQID: 2 claimed protein;56: PN: US20090011997SEQID: 59 claimed protein;82: PN: US20080153747 SEQID: 82 claimed protein;Atriopeptin (human a-component);Carperitide;Horse atrial natriuretic peptide-28;Humanatrial natriuretic factor (99-126);Human atrial natriuretic peptide (1-28);Human atrial natriuretic peptide (99-126);Human atriopeptin(1-28);Humanatriopeptin(99-126);Human atriopeptin-28;Human a-atrial natriuretic factor;Human a-atrial natriuretic factor(1-28);Human a-atrial natriuretic peptide;Human a-atriopeptin;L-Tyrosine,L-seryl-L-leucyl-L-arginyl-L-arginyl-L-seryl-L-seryl-L-cysteinyl-L-phenylalanylglycylglycyl-L-arginyl-L-methionyl-L-a-aspartyl-L-arginyl-L-isoleucylglycyl-L-alanyl-L-glutaminyl-L-serylglycyl-L-leucylglycyl-L-cysteinyl-L-asparaginyl-L-seryl-L-phenylalanyl-L-arginyl-,cyclic (7?;SUN 4936;[99-126]-Human proatriopeptin;a-Atriopeptin (human);a-Human atrial natriuretic hormone;a-Human atrial natriuretic peptide (1-28);a-Human atrial natriureticpolypeptide;a-Humanatriopeptin(1-28);
Molecular FormulaC127H203N45O39S3
Molecular Weight2512.81
refractive index1.688
Safety
Human atrial natriuretic peptide (99-126) (CAS NO.189213-87-6) is a poison by intravenous route. Experimental reproductive effects. When Human atrial natriuretic peptide (99-126) (CAS NO.189213-87-6) is heated to decomposition, it emits toxic vapors of NOx and SOx.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| dog |
LD50 |
intravenous |
> 100mg/kg (100mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 37, Pg. 1383, 1995. |
| mouse |
LD50 |
intravenous |
> 100mg/kg (100mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 37, Pg. 1383, 1995. |
| rat |
LD50 |
intravenous |
21mg/kg (21mg/kg) |
|
Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 37, Pg. 1383, 1995. |
